Literature DB >> 19005881

BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.

Zeping Zhou1, Zhenping Chen, Hongqiang Li, Xiaoli Chen, Jianhui Xu, Dongsheng Gu, Weiting Du, Cuiling Zheng, Lei Zhang, Ying Huang, Qian Ren, Renchi Yang.   

Abstract

BAFF (B-cell activating factor belonging to the TNF family) is an essential component of B-cell homeostasis, and is required for the normal survival and development of B cells. To further explore the role of this cytokine in the pathogenesis of idiopathic thrombocytopenic purpura (ITP), BAFF/BAFF-R (one of receptors of BAFF) expression levels were determined and the correlation between the clinical parameters and the BAFF expression levels was analyzed. A total of 57 patients with ITP were enrolled and 25 age and sex-matched healthy volunteers served as controls. Serum was obtained from 41 patients with ITP and 22 healthy volunteers and was analyzed with a commercial human soluble BAFF (sBAFF) ELISA kit. BAFF and BAFF-R mRNA expression of peripheral blood (PB) (n = 42) and splenocytes (SP) (n = 8) mononuclear cells (MNC) were determined by real-time quantitative PCR. The SPMNC of normal controls came from three hereditary spherocytosis patients who underwent splenectomy. The untreated patients with ITP had higher serum BAFF levels (Median 1430 pg/ml, Range: 534-5787 pg/ml) than those of normal controls (Median 1120 pg/ml, Range: 640-2376 pg/ml, p = 0.006) and treated ITP group (Median 662 pg/ml, Range 267-1265 pg/ml, p = 0.000). On the other hand, serum BAFF levels of treated patients with ITP were lower than those of normal controls (p = 0.001). There was a weak correlation (the Pearson correlation coefficient is - 0.242) between platelet count and BAFF (p = 0.064). However, BAFF levels did not correlate with platelet associated immunoglobulin or immunoglobulin levels. Moreover, the serum BAFF levels were not statistically different between acute and chronic ITP (p = 0.841). PBMNC of ITP had higher BAFF but not BAFF-R mRNA expression than that of normal controls. BAFF mRNA expression of SPMNC had a positive correlation with BAFF-R in ITP patients but not in PBMNC of normal controls and untreated ITP patients. The BAFF-R mRNA expression of SPMNC was shown to be 15.29 times higher than that of PBMNC in ITP. BAFF might contribute to autoimmunity and disease development in ITP. However, BAFF serum level must be carefully considered as a surrogate marker of disease activity in ITP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19005881     DOI: 10.1080/08916930802397848

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  9 in total

Review 1.  Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Authors:  Lisa J Toltl; Ishac Nazi; Reza Jafari; Donald M Arnold
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

2.  Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients.

Authors:  Zhenhai Zhou; Xiaoyin Li; Juan Li; Chang Su; Lan Zhuang; Shaokai Luo; Ling Zhang
Journal:  J Clin Immunol       Date:  2010-07-14       Impact factor: 8.317

3.  Neutrophils contribute to elevated BAFF levels to modulate adaptive immunity in patients with primary immune thrombocytopenia by CD62P and PSGL1 interaction.

Authors:  Pengcheng Xu; Xia Shao; Yang Ou; Yanxia Zhan; Lili Ji; Xibing Zhuang; Ying Li; Yanna Ma; Duojiao Wu; Tiankui Qiao; Xiangdong Wang; Hao Chen; Yunfeng Cheng
Journal:  Clin Transl Immunology       Date:  2022-06-28

4.  High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia.

Authors:  Xiao-juan Zhu; Yan Shi; Jian-zhi Sun; Ning-ning Shan; Jun Peng; Cheng-shan Guo; Ping Qin; Ming Hou
Journal:  J Clin Immunol       Date:  2009-06-05       Impact factor: 8.317

5.  B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis.

Authors:  Sara A J Thompson; Joanne L Jones; Amanda L Cox; D Alastair S Compston; Alasdair J Coles
Journal:  J Clin Immunol       Date:  2009-09-10       Impact factor: 8.317

6.  Pathway of Toll-like receptor 7/B cell activating factor/B cell activating factor receptor plays a role in immune thrombocytopenia in vivo.

Authors:  Qing Yang; Shuqian Xu; Xiaofang Li; Bo Wang; Xuping Wang; Daoxin Ma; Lei Yang; Jun Peng; Ming Hou
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

Review 7.  Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms.

Authors:  Claudia Cristina Tărniceriu; Loredana Liliana Hurjui; Irina Daniela Florea; Ion Hurjui; Irina Gradinaru; Daniela Maria Tanase; Carmen Delianu; Anca Haisan; Ludmila Lozneanu
Journal:  Medicina (Kaunas)       Date:  2022-02-01       Impact factor: 2.430

8.  Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population.

Authors:  Hend Nabil Ellithy; Sherif Mohamed Yousry; Asmaa Abdel-Aal; Lelian Tawadros; Nouran Momen
Journal:  Blood Res       Date:  2022-08-03

9.  Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia.

Authors:  Tian-Shu Yu; Hao-Yi Wang; Ya-Jing Zhao; Ya-Fei Yu; Yu Hou; Shuang Liu; Pan-Pan Han; Xiao-Fei Ni; Xue-Bin Ji; Jun Peng; Xin-Guang Liu; Ming Hou
Journal:  Blood Adv       Date:  2021-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.